Does MIRABEGRON Cause Mobility decreased? 438 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 438 reports of Mobility decreased have been filed in association with MIRABEGRON (MIRABEGRON). This represents 2.1% of all adverse event reports for MIRABEGRON.
438
Reports of Mobility decreased with MIRABEGRON
2.1%
of all MIRABEGRON reports
406
Deaths
367
Hospitalizations
How Dangerous Is Mobility decreased From MIRABEGRON?
Of the 438 reports, 406 (92.7%) resulted in death, 367 (83.8%) required hospitalization, and 364 (83.1%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MIRABEGRON. However, 438 reports have been filed with the FAERS database.
What Other Side Effects Does MIRABEGRON Cause?
Drug ineffective (4,151)
Off label use (1,704)
Intentional product misuse (1,416)
Dizziness (1,297)
Headache (1,288)
Blood pressure increased (1,100)
Hypertension (1,057)
Dry mouth (1,034)
Diarrhoea (921)
Pain (921)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which MIRABEGRON Alternatives Have Lower Mobility decreased Risk?
MIRABEGRON vs MIRALAX
MIRABEGRON vs MIRCERA
MIRABEGRON vs MIRENA
MIRABEGRON vs MIRIKIZUMAB-MRKZ
MIRABEGRON vs MIRTAZAPINE